Deep Track Capital’s Reata Pharmaceuticals RETA Stock Holding History
Bought
Maintained
Sold
Other funds holding RETA
CI
Deep Track Capital's RETA Position: Q2 2023 in Review
Deep Track Capital sold out of Reata Pharmaceuticals (RETA) in Q2 2023, closing a stake of 729,000 shares — an estimated $66.3M sold.
Deep Track Capital first reported a position in RETA in Q1 2023 and held it in 1 quarter. The position peaked at $66.3M in Q1 2023. 213 funds tracked by Wall St. Rank hold RETA as of Q2 2023.
- Deep Track Capital reported no remaining Reata Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
- Deep Track Capital sold 729,000 Reata Pharmaceuticals shares in Q2 2023, an estimated $66.3M.
- Deep Track Capital first reported a position in Reata Pharmaceuticals in Q1 2023 and held it in 1 quarter.
- Deep Track Capital's Reata Pharmaceuticals position peaked at $66.3M in Q1 2023.
- 213 funds tracked by Wall St. Rank held Reata Pharmaceuticals as of Q2 2023.
Based on Deep Track Capital's 13F filing for Q2 2023, filed 14 Aug 2023.